215 related articles for article (PubMed ID: 34943984)
1. Imidazole-Thiosemicarbazide Derivatives as Potent Anti-
Bekier A; Kawka M; Lach J; Dziadek J; Paneth A; Gatkowska J; Dzitko K; Dziadek B
Cells; 2021 Dec; 10(12):. PubMed ID: 34943984
[No Abstract] [Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
Papadopoulou MV; Bloomer WD; Rosenzweig HS
Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
5. Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity.
Popovici C; Pavel CM; Sunel V; Cheptea C; Dimitriu DG; Dorohoi DO; David D; Closca V; Popa M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830021
[TBL] [Abstract][Full Text] [Related]
6. Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).
Fan X; Xu J; Files M; Cirillo JD; Endsley JJ; Zhou J; Endsley MA
Tuberculosis (Edinb); 2019 May; 116S():S28-S33. PubMed ID: 31080089
[TBL] [Abstract][Full Text] [Related]
7. Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances
Moreira JD; Koch BEV; van Veen S; Walburg KV; Vrieling F; Mara Pinto Dabés Guimarães T; Meijer AH; Spaink HP; Ottenhoff THM; Haks MC; Heemskerk MT
Front Immunol; 2020; 11():36. PubMed ID: 32117228
[TBL] [Abstract][Full Text] [Related]
8.
Antoci V; Cucu D; Zbancioc G; Moldoveanu C; Mangalagiu V; Amariucai-Mantu D; Aricu A; Mangalagiu II
Future Med Chem; 2020 Feb; 12(3):207-222. PubMed ID: 31916456
[No Abstract] [Full Text] [Related]
9. Recent advances of imidazole-containing derivatives as anti-tubercular agents.
Fan YL; Jin XH; Huang ZP; Yu HF; Zeng ZG; Gao T; Feng LS
Eur J Med Chem; 2018 Apr; 150():347-365. PubMed ID: 29544148
[TBL] [Abstract][Full Text] [Related]
10. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
[TBL] [Abstract][Full Text] [Related]
11. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages.
Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ
J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743
[TBL] [Abstract][Full Text] [Related]
12. Naphthofuroquinone derivatives show strong antimycobacterial activities against drug-resistant Mycobacteria.
Jang WS; Choi YS; Kim S; Jyoti MA; Seo H; Han J; Kim YS; Lyu J; Nam KW; Lee BE; Lee KI; Song HY
J Chemother; 2017 Dec; 29(6):338-343. PubMed ID: 28281912
[TBL] [Abstract][Full Text] [Related]
13. Anti-mycobacterial activity of some medicinal plants used traditionally by tribes from Madhya Pradesh, India for treating tuberculosis related symptoms.
Gupta VK; Kaushik A; Chauhan DS; Ahirwar RK; Sharma S; Bisht D
J Ethnopharmacol; 2018 Dec; 227():113-120. PubMed ID: 30172059
[TBL] [Abstract][Full Text] [Related]
14. Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives.
Keng Yoon Y; Ashraf Ali M; Choon TS; Ismail R; Chee Wei A; Suresh Kumar R; Osman H; Beevi F
Biomed Res Int; 2013; 2013():926309. PubMed ID: 24381946
[TBL] [Abstract][Full Text] [Related]
15. Replication rates of Mycobacterium tuberculosis in human macrophages do not correlate with mycobacterial antibiotic susceptibility.
Raffetseder J; Pienaar E; Blomgran R; Eklund D; Patcha Brodin V; Andersson H; Welin A; Lerm M
PLoS One; 2014; 9(11):e112426. PubMed ID: 25386849
[TBL] [Abstract][Full Text] [Related]
16. Hit Compounds and Associated Targets in Intracellular
Tsui CKM; Sorrentino F; Narula G; Mendoza-Losana A; Del Rio RG; Herrán EP; Lopez A; Bojang A; Zheng X; Remuiñán-Blanco MJ; Av-Gay Y
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889319
[No Abstract] [Full Text] [Related]
17. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections.
Heemskerk MT; Korbee CJ; Esselink JJ; Dos Santos CC; van Veen S; Gordijn IF; Vrieling F; Walburg KV; Engele CG; Dijkman K; Wilson L; Verreck FAW; Ottenhoff THM; Haks MC
Sci Rep; 2021 Oct; 11(1):19634. PubMed ID: 34608194
[TBL] [Abstract][Full Text] [Related]
18. Allyl piperidine-1-carbodiothioate and benzyl 1H-imidazole 1 carbodithioate: two potential agents to combat against mycobacteria.
Mukherjee G; Mukherjee K; Das R; Mandal RS; Roy I; Mukhopadhyay B; Sil AK
J Appl Microbiol; 2021 Mar; 130(3):786-796. PubMed ID: 32615006
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel acetohydroxyacid synthase inhibitors as active agents against Mycobacterium tuberculosis by virtual screening and bioassay.
Wang D; Zhu X; Cui C; Dong M; Jiang H; Li Z; Liu Z; Zhu W; Wang JG
J Chem Inf Model; 2013 Feb; 53(2):343-53. PubMed ID: 23316686
[TBL] [Abstract][Full Text] [Related]
20. Impact of
Camassa S; Palucci I; Iantomasi R; Cubeddu T; Minerva M; De Maio F; Jouny S; Petruccioli E; Goletti D; Ria F; Sali M; Sanguinetti M; Manganelli R; Rocca S; Brodin P; Delogu G
Front Cell Infect Microbiol; 2017; 7():137. PubMed ID: 28484686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
